Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer’s disease model

BACKGROUND: Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that lacks any disease-modifying drug for the prevention and treatment. Edaravone (EDR), an approved free radical scavenger, has proven to have potential against AD by targeting multiple key pathologies including amyloi...

Full description

Saved in:
Bibliographic Details
Published in:Drug Des Devel Ther
Main Authors: Parikh, Ankit, Kathawala, Krishna, Li, Jintao, Chen, Chi, Shan, Zhengnan, Cao, Xia, Wang, Yan-Jiang, Garg, Sanjay, Zhou, Xin-Fu
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042531/
https://ncbi.nlm.nih.gov/pubmed/30022810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S161944
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items